214
Participants
Start Date
July 31, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
CKD-501 0.5mg
0.5 mg/tablet, orally, 1 tablet once daily for 8 weeks
CKD-501 1mg
1 mg/tablet, orally, 1 tablet once daily for 8 weeks
CKD-501 2mg
2 mg/tablet, orally, 1 tablet once daily for 8 weeks
Placebo
orally, 1 tablet once daily for 8 weeks
The Inje University Medical Center, Busan
The Yeungnam University Hospital, Daegu
The Chtholic University of Korea Uijeongbu St. Mary's Hospital, Gyeonggi-do
The Seoul National Univertisy Bundang Hospital, Gyeonggi-do
The Wonju Christian Hospital, Kangwon-Do
The Inje University Sanggye-Paik Hospital, Seoul
The Korea University Anam Hospital, Seoul
The Samsung Medical Center, Seoul
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY